US health officials on Thursday greenlit a first-of-its-kind gene therapy to treat a rare form of hereditary hearing loss, a breakthrough which could pave the way for other such hearing impairment treatments.

Two to three of every 1,000 children in the United States are born with a hearing impairment, and it is estimated that more than half of these cases of early-onset hearing loss are caused by genetic mutations.